Protara Therapeutics (TARA) Shares Issued (2013 - 2026)

Protara Therapeutics (TARA) has 14 years of Shares Issued data on file, last reported at $1.2 million in Q1 2026.

• On a quarterly basis, Shares Issued fell 75.72% year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $1.2 million, a 75.72% decrease from a year earlier, with the FY2025 full-year figure at $3.5 million, down 37.86% from the prior year.
• Shares Issued for Q1 2026 stood at $1.2 million, down from $3.5 million in the prior quarter.
• Over the last five years, Shares Issued for TARA reached as high as $5.7 million in Q4 2024 and fell as low as $46112.0 in Q1 2024.
• Historically, Shares Issued has averaged $2.6 million across 5 years, with a median of $2.0 million in 2023.
• Across the five-year window, Shares Issued slumped 98.45% in 2024 and surged 10555.11% in 2025, its largest moves.
• Year by year, Shares Issued stood at $1.8 million in 2022, then surged by 58.63% to $2.9 million in 2023, then soared by 96.33% to $5.7 million in 2024, then sank by 37.86% to $3.5 million in 2025, then plunged by 66.28% to $1.2 million in 2026.
• Per Business Quant data, the three most recent Shares Issued figures were $1.2 million in Q1 2026, $3.5 million in Q4 2025, and $5.6 million in Q3 2025.